share_log
Moomoo 24/7 ·  Apr 23 13:12
Tandem Diabetes Care Shares Are Trading Higher. Stifel Maintained Its Buy Rating on the Stock and Raised Its PT Rom $37 to $40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment